The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Treatment adherence to anti‐tumor necrosis factor alpha (anti‐TNF‐α) agents is marker of treatment success, but overall efficacy of anti‐TNF‐α therapy decreases over time leading to a progressive loss of adherence. The present observational study was conducted in order to estimate the long‐term adherence to etanercept in patients affected by plaque‐type psoriasis, evaluating differences among intermittent...
Overexpression of tumor necrosis factor alpha (TNF‐α) has been demonstrated to play a pivotal role in the pathogenesis of both plaque‐type psoriasis and psoriatic arthritis. TNF‐α blockers, including etanercept, a human protein that acts as a TNF‐α soluble receptor, are effective in the treatment of psoriasis. This retrospective study investigated the impact of psoriasis patients’ demographic and...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.